ES2163085T3 - Utilizacion de un extracto de cimicifuga racemosa. - Google Patents

Utilizacion de un extracto de cimicifuga racemosa.

Info

Publication number
ES2163085T3
ES2163085T3 ES97121030T ES97121030T ES2163085T3 ES 2163085 T3 ES2163085 T3 ES 2163085T3 ES 97121030 T ES97121030 T ES 97121030T ES 97121030 T ES97121030 T ES 97121030T ES 2163085 T3 ES2163085 T3 ES 2163085T3
Authority
ES
Spain
Prior art keywords
racemosa
extract
cimicifuga extract
cimicifuga
racemous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97121030T
Other languages
English (en)
Inventor
Thomas Dr Nesselhut
Cornelia Bodinet
Peter Dr Schneider
Johannes Dr Freundenstein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Schaper und Bruemmer GmbH and Co KG
Original Assignee
Schaper und Bruemmer GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schaper und Bruemmer GmbH and Co KG filed Critical Schaper und Bruemmer GmbH and Co KG
Application granted granted Critical
Publication of ES2163085T3 publication Critical patent/ES2163085T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Seasonings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

LA ACCION DE UNA SUSTANCIA ANTIESTROGENICA UTILIZADA PARA EL TRATAMIENTO DE TUMORES DEPENDIENTES DE ESTROGENOS SE POTENCIA MEDIANTE LA ADMINISTRACION SIMULTANEA DE UN EXTRACTO DE CIMIFUGA RACEMOSA, PREFERENTEMENTE EN DOSIFICACIONES ENTRE 5 MG Y 500 MG DE FARMACO AL DIA.
ES97121030T 1996-12-14 1997-11-29 Utilizacion de un extracto de cimicifuga racemosa. Expired - Lifetime ES2163085T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19652183A DE19652183C1 (de) 1996-12-14 1996-12-14 Verwendung eines Extraktes aus Cimicifuga racemosa

Publications (1)

Publication Number Publication Date
ES2163085T3 true ES2163085T3 (es) 2002-01-16

Family

ID=7814802

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97121030T Expired - Lifetime ES2163085T3 (es) 1996-12-14 1997-11-29 Utilizacion de un extracto de cimicifuga racemosa.

Country Status (13)

Country Link
US (1) US6267994B1 (es)
EP (1) EP0847755B1 (es)
AT (1) ATE205721T1 (es)
AU (2) AU730372B2 (es)
CA (1) CA2245890C (es)
DE (2) DE19652183C1 (es)
DK (1) DK0847755T3 (es)
ES (1) ES2163085T3 (es)
HU (1) HU224316B1 (es)
IL (1) IL125776A (es)
NO (1) NO316106B1 (es)
PL (1) PL187264B1 (es)
WO (1) WO1998026791A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19812204A1 (de) * 1998-03-19 1999-11-04 Plantamed Arzneimittel Gmbh Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
ES2249278T3 (es) * 1999-07-15 2006-04-01 Kobenhavns Universitet Composicion con efecto estrogeno esteroideo sin aumento de riesgo de cancer de mama.
DE10054641A1 (de) * 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
DE10146159A1 (de) * 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
DE10206390A1 (de) * 2002-02-15 2003-08-28 Bionorica Ag Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten
US20030224068A1 (en) * 2002-06-03 2003-12-04 Ven Subbiah Compounds for hormonal therapy
US20030224069A1 (en) * 2002-06-03 2003-12-04 Ven Subbiah Triterpene glycosides for hormonal therapy
DE60334378D1 (de) * 2002-07-05 2010-11-11 Temrel Ltd Zusammensetzung zur kontrollierten wirkstoffabgabe
US20090186837A1 (en) 2002-12-27 2009-07-23 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
US20090264377A1 (en) * 2002-12-27 2009-10-22 Linda Saxe Einbond Anti-neoplastic compositions comprising extracts of black cohosh
US7407675B2 (en) * 2002-12-27 2008-08-05 The Trustees Of Columbia University In The City Of New York Anti-neoplastic compositions comprising extracts of black cohosh
JP2004307445A (ja) * 2003-04-02 2004-11-04 Pharmaton Sa Ｓｅｒｍの副作用を改善する方法
US20040228931A1 (en) * 2003-05-12 2004-11-18 Pharmachem Laboratories, Inc. Novel composition for hormonal balance and uses thereof
EP1644015B1 (en) * 2003-07-01 2008-02-27 Max Zeller Söhne AG Plant extraction method and extract
DE102005005276A1 (de) * 2005-02-04 2006-08-10 Peter Heger Verwendung von Hydroxystilben-haltigen Wirkstoffen zur Chemoprävention der Tumorgenese und/oder zur Inhibition der Tumorprogression bei endokrin-abhängigen und endokrin-unabhängigen Tumoren
AU2013285492B2 (en) 2012-07-03 2015-11-12 Max Zeller Soehne Ag Novel pharmacological use of Cimicifuga extract
WO2020141083A1 (en) * 2018-12-31 2020-07-09 Max Zeller Soehne Ag Combination of cimicifuga and petasites extracts for anticancer therapy and prophylaxis
IT201900000343A1 (it) 2019-01-10 2020-07-10 Herbal E Antioxidant Derivatives S R L Ed In Forma Abbreviata H&Ad S R L Composizioni per il trattamento della menopausa, osteopenia e osteoporosi, disturbi metabolici e vascolari legati al climaterio

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02255622A (ja) * 1989-03-28 1990-10-16 Tsumura & Co 制癌補助剤
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders

Also Published As

Publication number Publication date
ATE205721T1 (de) 2001-10-15
DE19652183C1 (de) 1998-02-12
IL125776A0 (en) 1999-04-11
DK0847755T3 (da) 2001-11-12
PL323617A1 (en) 1998-06-22
AU4830097A (en) 1998-06-18
AU5549098A (en) 1998-07-15
EP0847755B1 (de) 2001-09-19
US6267994B1 (en) 2001-07-31
NO975858D0 (no) 1997-12-12
HUP9901360A2 (hu) 1999-08-30
AU730372B2 (en) 2001-03-08
PL187264B1 (pl) 2004-06-30
HU224316B1 (hu) 2005-07-28
CA2245890A1 (en) 1998-06-25
NO316106B1 (no) 2003-12-15
CA2245890C (en) 2010-05-25
IL125776A (en) 2003-12-10
HUP9901360A3 (en) 2000-02-28
WO1998026791A1 (de) 1998-06-25
EP0847755A1 (de) 1998-06-17
DE59704654D1 (de) 2001-10-25
NO975858L (no) 1998-06-15

Similar Documents

Publication Publication Date Title
ES2163085T3 (es) Utilizacion de un extracto de cimicifuga racemosa.
MX9700082A (es) Composicion que consiste de morfina, polipirrolidona y oxido de polialquileno.
PT86536A (pt) Sistema terapeutico para ingredientes activos pouco soluveis
SE8803486D0 (sv) Dosage form for treating cardiovascular diseases
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
ES2161288T3 (es) Comprimido revestido con polimero que comprende amoxicilina y clavulanato.
ES2179096T3 (es) Utilizacion de la interleucina-12 para prevenir la reaccion del injerto contra el huesped.
PT777482E (pt) Composicao de combinacao para utilizacao em doencas imunologicas
ES2063202T3 (es) Nuevas 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepin-6-onas y -tionas y su uso en la prevencion o tratamiento del sida.
BR0016138B1 (pt) formulaÇço farmacÊutica adequada para a administraÇço intranasal, uso de zolmitriptan, e, dispositivo de administraÇço intranasal
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
ES542430A0 (es) Un procedimiento para la preparacion de una composicion antiacida de alginato de magnesio.
ES2184341T3 (es) Un metodo para la prevencion y el tratamiento de la disfuncion del miocardio.
ES2194104T3 (es) Uso de selegilina para el tratamiento de la perdida de audicion en mamiferos.
BG103262A (en) Antimycotic gel with high degree of active substance release
ES2191206T3 (es) Nueva utilizacion de la creatina.
ATE218881T1 (de) Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin
JPS57181072A (en) Oxaprodine derivative
RU94039553A (ru) Средство для лечения хронического простатита
NO981320L (no) Oral anvendelse av (+)-O-demetyltramadol som smertemiddel
AR007294A1 (es) Nuevo uso de derivados de cistina
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
ES2139382T3 (es) Sistema terapeutico percutaneo para compuestos de silatran.
GEP20002230B (en) Medicinal Means "Dosental" for Acute and Chronic Inflammations
MX9100974A (es) Enzima fibrinolitica hibrida y procedimiento para su preparacion.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 847755

Country of ref document: ES